SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 189 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $67,055 | -37.3% | 21,355 | -17.5% | 0.00% | – |
| Q2 2022 | $107,000 | +1.9% | 25,900 | +42.7% | 0.00% | – |
| Q1 2022 | $105,000 | -82.3% | 18,147 | -80.5% | 0.00% | -100.0% |
| Q1 2020 | $592,000 | +72.1% | 92,994 | +126.1% | 0.01% | +250.0% |
| Q4 2019 | $344,000 | +84.9% | 41,131 | +138.2% | 0.00% | +100.0% |
| Q2 2019 | $186,000 | -37.2% | 17,264 | -33.1% | 0.00% | -50.0% |
| Q4 2018 | $296,000 | +36.4% | 25,806 | +78.6% | 0.00% | +100.0% |
| Q3 2017 | $217,000 | -93.0% | 14,451 | -95.9% | 0.00% | -92.3% |
| Q2 2017 | $3,095,000 | +212.6% | 351,700 | +114.8% | 0.01% | +116.7% |
| Q1 2016 | $990,000 | -93.2% | 163,697 | -89.8% | 0.01% | -94.1% |
| Q4 2015 | $14,653,000 | +3260.8% | 1,604,890 | +1977.5% | 0.10% | +3300.0% |
| Q3 2015 | $436,000 | -96.1% | 77,252 | -89.6% | 0.00% | -97.1% |
| Q4 2014 | $11,268,000 | +480.5% | 740,857 | +311.6% | 0.10% | +586.7% |
| Q3 2014 | $1,941,000 | -61.2% | 180,000 | -34.9% | 0.02% | -73.7% |
| Q1 2014 | $5,001,000 | +80.5% | 276,600 | +38.7% | 0.06% | +58.3% |
| Q4 2013 | $2,771,000 | – | 199,465 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIC CAPITAL INC | 875,284 | $2,670,000 | 1.34% |
| NEXTHERA CAPITAL LP | 503,000 | $1,534,000 | 0.90% |
| Opaleye Management Inc. | 400,000 | $1,220,000 | 0.72% |
| WASATCH ADVISORS LP | 7,256,260 | $22,132,000 | 0.33% |
| Cormorant Asset Management, LP | 650,000 | $1,983,000 | 0.27% |
| Sicart Associates LLC | 101,950 | $311,000 | 0.22% |
| Baker Brothers Advisors | 4,055,876 | $12,370,000 | 0.12% |
| Leisure Capital Management | 43,008 | $131,000 | 0.12% |
| Piermont Capital Management Inc. | 165,569 | $505,000 | 0.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 837,963 | $2,556,000 | 0.10% |